ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC), Eur J Heart Fail, 2016. ,
ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America, J Am Coll Cardiol, 2016. ,
Heart failure drug treatment, Lancet, vol.2019, pp.1034-1044, 10175. ,
URL : https://hal.archives-ouvertes.fr/hal-02510811
Diuretic Treatment in Heart Failure, N Engl J Med, United States, vol.378, pp.684-685, 2018. ,
Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD), J Am Coll Cardiol, vol.42, issue.4, pp.705-713, 2003. ,
The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study, Cardiovasc Drugs Ther, vol.15, issue.1, pp.79-87, 2001. ,
Prognostic Value of Estimated Plasma Volume in Heart Failure, JACC Heart Fail, vol.2015, issue.11, pp.886-93 ,
URL : https://hal.archives-ouvertes.fr/hal-01236515
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy, J Am Coll Cardiol, vol.58, issue.19, pp.1958-66, 2011. ,
Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence from the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial, 2016. ,
Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF), Circ Heart Fail, vol.8, issue.4, pp.741-749, 2015. ,
Tackling Early Heart Failure Deaths and Readmissions by Estimating Congestion, JACC Heart Fail, vol.2015, issue.11, pp.894-899 ,
, N Engl J Med, 2019.
The specific mineralocorticoid receptor blocker eplerenone attenuates left ventricular remodeling in mice lacking the gene encoding guanylyl cyclase-A, Hypertens Res, issue.6, pp.1251-1257, 2008. ,
Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study, Eur Heart J, Published on behalf of the European Society of Cardiology The Author, vol.35, pp.2295-302, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01738642
Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study, Circulation, vol.2012, issue.2, pp.271-280 ,